IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study

Clinical trial NCT05417269 · UNKNOWN

Trial details

NCT number: NCT05417269
Sponsor: Imcyse SA
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2022-04-12
Primary completion: 2025-05-23
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.